Innovations in Personalized Diabetes Care and Risk Management

Early Identification of Metabolic Syndrome Risk

Improving Risk Stratification for Patients with Type 2 Myocardial Infarction

Comparisons of Polyexposure, Polygenic and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes

Clinical Utility of Cardiovascular Risk Scores for Identification of People with T2D More Likely to Benefit from Either GLP1 Receptor Agonists or SGLT2 Inhibitor Therapy

Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients with Diabetes

Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients with Diabetes

CRP, C-Peptide and Risk of First Time Cardiovascular Events and Mortality in Early T2D: A Danish Cohort Study

Risk Assessment in Patients with Diabetes with the TIMI Risk Score for Atherothrombotic Disease

Associations of New-Onset Atrial Fibrillation with Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients with Type 2 Diabetes

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype

Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and chronic kidney disease

Risk stratification using Artificial Intelligence